相似文献
1
Modulators of P-glycoprotein-associated multidrug resistance.
Cancer Treat Res. 1991;57:151-70. doi: 10.1007/978-1-4615-3872-1_7.
2
Clinical implications of multidrug resistance to chemotherapy.
Cancer Treat Res. 1991;57:171-86. doi: 10.1007/978-1-4615-3872-1_8.
3
Reversal of multidrug resistance.
Cancer Treat Rev. 1990 Dec;17 Suppl A:37-43. doi: 10.1016/0305-7372(90)90014-7.
4
5
The role of P-glycoprotein in drug-resistant hematologic malignancies.
Cancer Treat Res. 1991;57:187-208. doi: 10.1007/978-1-4615-3872-1_9.
6
Multidrug resistance: molecular biology and clinical relevance.
J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.
7
Multidrug resistance in human cancer.
Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.
8
Cooperative P-glycoprotein mediated daunorubicin transport into DNA-loaded plasma membrane vesicles.
FEBS Lett. 1994 Jun 13;346(2-3):141-5. doi: 10.1016/0014-5793(94)00447-1.
9
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Cancer Chemother Pharmacol. 1994;34(2):125-32. doi: 10.1007/BF00685929.
10
Reversal of multidrug resistance in cancer cells.
J Natl Cancer Inst. 1994 Jan 19;86(2):148-50. doi: 10.1093/jnci/86.2.148.
引用本文的文献
1
Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.
Tumour Biol. 2012 Aug;33(4):943-56. doi: 10.1007/s13277-012-0323-5. Epub 2012 Jan 31.
2
Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.
Cytotechnology. 1998 Sep;27(1-3):113-36. doi: 10.1023/A:1008052401952.
3
Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers.
Pharm Res. 2000 May;17(5):533-8. doi: 10.1023/a:1007508714259.
Zotero 插件